<DOC>
	<DOC>NCT01647646</DOC>
	<brief_summary>In real life, the investigators will be using different strategies including SMART therapy or other ICS/LABA (medium and high dose) therapy and measure the efficacy for asthma control.</brief_summary>
	<brief_title>Real Life Effectiveness in Patients With Not Optimally Controlled Asthma</brief_title>
	<detailed_description>1. All not-well controlled asthma patients would include the study. 2. We will compare three ways of asthma control including SMART, fixed doses with regular doses and fixed doses with higher doses 3. We will evaluate the efficacy/safety for these not-well controlled patients.</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Fluticasone Propionate, Salmeterol Xinafoate Drug Combination</mesh_term>
	<criteria>asthma not well control COPD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>asthma</keyword>
	<keyword>SMART</keyword>
	<keyword>fixed dose</keyword>
</DOC>